Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells

被引:0
作者
Cheng Jiang
Junming Guo
Zhe Wang
Bingxiu Xiao
Hyo-Jung Lee
Eun-Ok Lee
Sung-Hoon Kim
Junxuan Lu
机构
[1] University of Minnesota,The Hormel Institute
[2] Ningbo University School of Medicine,Cancer Preventive Material Development Research Center (CPMDRC), College of Oriental Medicine
[3] Kyunghee University,undefined
[4] Hoegi-dong,undefined
来源
Breast Cancer Research | / 9卷
关键词
Tamoxifen; Fulvestrant; Estrogen Stimulation; Faslodex; Decursinol Angelate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 44 条
  • [21] iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity
    María Inés Diaz Bessone
    Lorena Simón-Gracia
    Pablo Scodeller
    María de los Angeles Ramirez
    María Amparo Lago Huvelle
    Galo J. A. A. Soler-Illia
    Marina Simian
    Journal of Nanobiotechnology, 17
  • [22] Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: A unifying concept in anti-hormone resistance
    Balaburski, Gregor M.
    Dardes, Rita C.
    Johnson, Michael
    Haddad, Bassem
    Zhu, Fang
    Ross, Eric A.
    Sengupta, Surojeet
    Klein-Szanto, Andres
    Liu, Hong
    Lee, Eun Sook
    Kim, Helen
    Jordan, V. Craig
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (02) : 387 - 398
  • [23] Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells
    Cliff Hurd
    Sumi Dinda
    Nidhi Khattree
    V K Moudgil
    Oncogene, 1999, 18 : 1067 - 1072
  • [24] Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells
    Hurd, C
    Dinda, S
    Khattree, N
    Moudgil, VK
    ONCOGENE, 1999, 18 (04) : 1067 - 1072
  • [25] Changes in the expression and binding properties of the estrogen receptor in MCF-7 breast cancer cells during growth inhibition by tamoxifen and cisplatin
    Otto, AM
    Schubert, S
    Netzker, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (04) : 305 - 311
  • [26] A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells
    Wang, Bo
    Li, Dongping
    Rodriguez-Juarez, Rocio
    Farfus, Allison
    Storozynsky, Quinn
    Malach, Megan
    Carpenter, Emily
    Filkowski, Jody
    Lykkesfeldt, Anne E.
    Kovalchuk, Olga
    BMC CANCER, 2018, 18
  • [27] A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells
    Bo Wang
    Dongping Li
    Rocio Rodriguez-Juarez
    Allison Farfus
    Quinn Storozynsky
    Megan Malach
    Emily Carpenter
    Jody Filkowski
    Anne E. Lykkesfeldt
    Olga Kovalchuk
    BMC Cancer, 18
  • [28] The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling
    Martin, LA
    Pancholi, S
    Farmer, I
    Johnston, SRD
    Dowsett, M
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S28 - S29
  • [29] The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling
    L-A Martin
    S Pancholi
    I Farmer
    SRD Johnston
    M Dowsett
    Breast Cancer Research, 7
  • [30] Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen
    Irna, IK
    Itoh, T
    Chen, SU
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 97 (04) : 360 - 368